ABOUT THE COMPANY
Analysis of the Financial Statements
ASM (Advanced Synergic Microsystems) Technologies Limited was incorporated in 1992, headquartered in Bengaluru, India with operations and delivery centers in India, USA, Singapore, UK, Canada, Mexico, and Japan. The company specializes in Engineering R&D (ER&D) services and Design-Led Manufacturing (DLM) solutions. It has two wholly owned subsidiaries Pinnacle Talent Inc. (USA) and Advanced Synergic Pte. Ltd. (Singapore). It signed an MoU with the Government of Karnataka (FY25) to invest ₹510 crore in expanding its DLM capabilities. The global E R&D spend is 1.5 – 1.8 trillion USD in 2024. With over 30 years of experience in E R&D, ASM serves global over 30 years of experience in automotive and aerospace and leverages its ER&D base to strengthen its DLM offerings.
Revenue Growth Trend
Revenue moved from 92 crores in 2020 to 289 crores in 2025 with a 6-year CAGR for revenues stands at 25.73%, outperforming the industry growth rate of 12-15%. It indicates that the annual growth is steady and consistent.
| MARCH 2020 | MARCH 2021 | MARCH 2022 | MARCH 2023 | MARCH 2024 | MARCH 2025 |
| 92 CRORES | 137 CRORES | 192 CRORES | 220 CRORES | 202 CRORES | 289 CRORES |
Profitability & Margin Analysis
Operating Profit has shown a compression in the past few years from 12% in 2021 to 3% in 2024 then expanded sharply in 2025 to 16%. It indicates that despite the revenue was rising the company was struggling to maintain its profits
| MARCH 2020 | MARCH 2021 | MARCH 2022 | MARCH 2023 | MARCH 2024 | MARCH 2025 |
| 3% | 12% | 11% | 9% | 3% | 16% |
Balance Sheet Strength
The total assets of the company have grown from 83 crores in March 2020 to 287 crores in March 2025 showing a subsequent investment into the Design-Led Manufacturing (DLM) facilities, technology upgrades implicating potential for higher capacity and future sales.
Debt Profile
Borrowings of the company increased from 23 crores in 2020 to 86 crores in 2025 showing an moderate increase in respect to the total assets of the company. Reserves showed a sharp increase, indicating a large portion of the assets are financed through retained earnings and not through debt. This makes the balance sheet healthier than if it was purely debt-driven.
Cash Flow Health
Operating cash flow of the company is not stable, indicating company is not able to convert its profit into cash. Profits to cash conversion are a problem, a red flag for the investors. Cash Conversion Cycle of the company has gone from 84 days to 176 days showing a large portion of the company cash is blocked for a longer period.
Analysis of the Company Management (Concall/Disclosures-based view)
As per the 2025 Q2 Investor’s presentation company is leading in the ALD (Atomic Layer Deposition) market, which is expected to grow by 10%-14%. In 2025 Q2 company has a gross margin of 51.8% and adjusted operating margin of 31.5%. New orders of ₹66,34,87,17,786 in Q2 2025 were down by 4% yoy at constant currencies (cc), mainly due to the lumpy nature of quarterly order intake and compared to a relatively high memory contribution in Q2 2024.
Disclaimer: The article is for informational purposes only and not investment advice.